U.S. RNAi Markets

/Home/Biologics Delivery - Protein Synthesis/Biologics Market Research - Protein Synthesis

U.S. RNAi Markets
Published by: Frost & Sullivan
Publication Date: 9 May 2006
For more information, contact Frost & Sullivan
This Frost & Sullivan research service entitled U.S. RNAi Markets provides revenue forecasts for individual market sectors as well as overall market, detailed market trends with specific applications forecasts, and market-wide challenge with corresponding strategic recommendations. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: Total RNAi Market, RNAi Content Market, RNAi Delivery Tools Market, and RNAi Screening and Analysis Tools Markets.
This analysis is available through our Drug Discovery Technologies Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils. For more information on this custom subscription service, please click here.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this analysis:
? RNAi Content
? RNAi Delivery Tools
? RNAi Screening and Analysis Tools

Technologies

The following technologies are covered in this research:
Custom, pre-designed, or validated siRNA; siRNA sets; genome-wide libraries;
shRNA; expression cassettes; miRNA
Lipid-based transfection reagents; RNAi-specific transfection reagents;
electroporation devices and buffers; viral vectors; nano-particle technologies
Quantitative real time PCR assays; Northern blot kits; gene expression arrays;
western blot kits; 2D gel electrophoresis consumables; proteomics arrays;
phenotypic assays

Market Overview

The U.S. RNAi markets are rapidly evolving as a growing number of scientists transition their research focus from low-throughput to medium- and high-throughput in one dimension, and from in vitro to in vivo in a second dimension. Numerous opportunities exist for vendors of RNAi content and tools, especially as technologies advance to provide greater selectivity and specificity of knockdown. RNAi technologies are proving to be indispensable tools for functional genomics research and for identifying and validating potential drug targets. RNAi has become a vital tool for examining both gene and protein expression analyses, especially with regards to understanding the pre- and post-transcriptional function of genes in relation to disease. Using RNAi, researchers are able to simply turn genes on and off and observe what happens, thereby gaining insights into how genes participate in cellular processes. RNAi is by far the most widely used gene-silencing technique employed in research.
The Frost & Sullivan study on U.S. RNAi markets provides a detailed examination of both quantitative aspects of the market and qualitative RNAi research trends. With thorough analyses of the transition to in vivo research and the shift towards high-throughput research, the study forecasts future revenues as well as future applications of various RNAi technologies. Furthermore, the study segments the market in an innovative way with market drivers, market restraints, technology trends, market trends, revenue forecasts, competitive landscape analyses, and market share analyses for the RNAi content market, RNAi delivery tools market, and RNAi screening and analysis tools market. This Frost & Sullivan study offers forecasts through 2012 concerning RNAi-related technologies such as siRNA, shRNA, miRNA, transfection reagents, electroporation devices, viral vectors, nanoparticle agents, gene expression assays, protein assays, and phenotypic assays.